Materials & Resources » Chemicals | Zhejiang Yongtai Technology Co. Ltd.

Zhejiang Yongtai Technology Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
78
372
443
737
603
872
Total Accounts Receivable
249
360
478
514
817
904
Inventories
368
384
478
529
649
656
Other Current Assets
16
29
49
99
209
152
Total Current Assets
711
1,146
1,447
1,879
2,277
2,585
Net Property, Plant & Equipment
854
947
1,149
1,561
2,065
2,454
Total Investments and Advances
166
137
240
251
247
119
Intangible Assets
235
274
473
557
1,178
1,375
Other Assets
2
1
106
193
49
41
Total Assets
1,972
2,518
3,437
4,465
5,864
6,648
ST Debt & Current Portion LT Debt
725
486
989
1,679
1,934
Accounts Payable
139
178
240
296
395
Income Tax Payable
-
5
17
51
22
Other Current Liabilities
17
59
157
55
106
Total Current Liabilities
881
727
1,403
2,081
2,457
Long-Term Debt
22
19
44
151
499
Provision for Risks & Charges
-
2
-
-
-
Deferred Taxes
3
11
21
15
32
Other Liabilities
-
16
28
-
-
Total Liabilities
904
767
1,477
2,242
2,972
Common Equity (Total)
1,005
1,689
1,872
2,093
2,674
Total Shareholders' Equity
1,005
1,689
1,872
2,093
2,674
Total Equity
1,046
1,730
1,912
2,147
2,792
Liabilities & Shareholders' Equity
1,972
2,518
3,437
4,465
5,864
Accumulated Minority Interest
41
40
39
54
118
Non-Equity Reserves
21
22
49
76
100

About Zhejiang Yongtai Technology Co.

View Profile
Address
Linhai Industrial Park
Taizhou Zhejiang 317016
China
Employees -
Website http://www.yongtaitech.com
Updated 07/08/2019
Zhejiang Yongtai Technology Co., Ltd. engages in the production, research, development, sale, and service of medicines, pesticides, electronic chemicals, and new energy lithium battery materials. Its products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, advanced intermediates, basic intermediates, pesticides, liquid crystal materials, and lithium battery materials. It also provides contract manufacturing services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.